BackCadrenal Therapeutics Overview

Cadrenal Therapeutics Receivables

Cadrenal Therapeutics's receivables is $5.5K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$5466.00
↓ 77.84% YoYΔ $-19198.00 vs prior year quarter

Peer average

Loading

Cadrenal Therapeutics Receivables History

Loading

Cadrenal Therapeutics vs. peers: Receivables Comparison

Loading

Cadrenal Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cadrenal Therapeutics (CVKD) FAQ

Cadrenal Therapeutics (CVKD) currently reports a receivables of $5.5K as of March 2026. That compares with $25K in the prior-year period — down 77.8% year over year. Use the charts on this page to explore Cadrenal Therapeutics's receivables history and peer comparisons.

Cadrenal Therapeutics's receivables decreased from $25K to $5.5K — a 77.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cadrenal Therapeutics reported $5.5K in receivables as of March 2026. That compares with $25K in the prior-year period — down 77.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $5.5K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cadrenal Therapeutics, and consider following CVKD for alerts when major investors trade the stock.